RankAlpha logo
Back to Rankings

URGN

UroGenF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
URGN vs peer average
24/100
URGN vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

KLRA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.4B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerKLRAKailera Therapeutics
URGN
UroGen
KLRA
Kailera Therapeutics
Grade
F
F
Momentum
89
4
Value
41
46
Sentiment
15
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs KLRA

URGN / KLRA
Grade Position
Below peers
URGN vs. peer average (F vs. C)
24/100
Momentum
89
URGN
Value
41
KLRA
Sentiment
15
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs URGN
1
KLRA
Kailera Therapeutics Inc Common
F
20/100
Even
2
CDNA
CareDx Inc Common
F
20/100
Even
3
AMLX
Amylyx Pharmaceuticals Inc Common
D
40/100
-1
4
PBH
Prestige Consumer Healthcare Inc Common
A
100/100
-4
5
BHC
Bausch Health Companies Inc Common
A
100/100
-4
KLRA is the first peer returned for this comparison set.